- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03068156
Efficacy of 308-nm Excimer Laser for Primary Localized Cutaneous Amyloidosis Treatment in Asians
February 26, 2017 updated by: Chulalongkorn University
Efficacy of 308-nm Excimer Laser for Primary Localized Cutaneous Amyloidosis Treatment in Asians: Pilot Study
Efficacy of 308-nm excimer laser for primary localized cutaneous amyloidosis treatment in Asians, pilot study.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
15
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Bangkok, Thailand, 10330
- Recruiting
- King Chulalongkorn Memorial Hospital
-
Sub-Investigator:
- Pawinee Rerknimitr, M.D.
-
Sub-Investigator:
- Chanat Kumtornrat, M.D.
-
Sub-Investigator:
- Kitipong Wantavornprasert, M.D.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients, aged >18 years old with lichen amyloidosis diagnosed by using clinical presentation and pathologic features
Exclusion Criteria:
- Those with cutaneous amyloidosis associated systemic diseases
- Pregnancy or lactating woman
- Those who are allergic to urea, olive oil
- Those who are photosensitive to ultraviolet radiation
- Those who had been previously treated with medications/ radiation/ laser within 3 months for systemic and 1 month for topical therapy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
NO_INTERVENTION: Control
|
|
EXPERIMENTAL: excimer laser
|
monochromator UVB laser (308nm)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Roughness evaluation by using Visioscan® VC98
Time Frame: Change from baseline roughness at every 2 weeks up to 16 weeks
|
The improvement of roughness evaluation
|
Change from baseline roughness at every 2 weeks up to 16 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
January 31, 2017
Primary Completion (ANTICIPATED)
January 30, 2018
Study Completion (ANTICIPATED)
March 2, 2018
Study Registration Dates
First Submitted
February 20, 2017
First Submitted That Met QC Criteria
February 26, 2017
First Posted (ACTUAL)
March 1, 2017
Study Record Updates
Last Update Posted (ACTUAL)
March 1, 2017
Last Update Submitted That Met QC Criteria
February 26, 2017
Last Verified
February 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CU_308excimer_amyloidosis
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lichen Amyloidosis
-
Chulalongkorn UniversityUnknown
-
Novartis PharmaceuticalsCompletedLichen Planus: Cutaneous Lichen Planus, Mucosal Lichen Planus and Lichen PlanopilarisGermany, United States, France
-
Medical University of GrazRecruitingLichen Planus | Lichen Sclerosus Et AtrophicusAustria
-
University of North Carolina, Chapel HillEli Lilly and CompanyRecruitingLichen Planus, Oral | Oral Lichen Planus | Lichen Planus, MucosalUnited States
-
Nourhan M.AlyAlexandria UniversityCompleted
-
University of New MexicoCompletedLichen Planus | Lichen Planopilaris | Lichen Planus ScalpUnited States
-
Alexandria UniversityCompletedEvaluation of Diode Laser and Topical Steroid Therapy in the Treatment of Erosive Oral Lichen PlanusErosive Oral Lichen PlanusEgypt
-
Cairo UniversityUnknownPatients With Oral Lichen PlanusEgypt
-
Pia Lopez JornetCompletedOral Lichen Planus | Oral Lichen Planus Related StressSpain
-
Fundación Eduardo AnituaNot yet recruiting
Clinical Trials on 308-nm excimer laser
-
Air Force Military Medical University, ChinaCompleted
-
The Catholic University of KoreaUnknownVitiligoKorea, Republic of
-
University of UtahAmerican Society for Dermatologic SurgeryCompleted
-
The Catholic University of KoreaUnknownRecurrence | Vitiligo | Maintenance Therapy | the 308-nm Excimer LaserKorea, Republic of
-
Phoenix Children's HospitalWithdrawn
-
Ra Medical SystemsCompletedPeripheral Arterial DiseaseUnited States
-
Instituto Vascular BHCompleted
-
Durrie VisionAlcon ResearchUnknown
-
College of CharlestonCompletedMuscle FatigueUnited States